NEWS / PRESS RELEASES
16.04.12
Hoffman - La Roche chooses the Montreal Heart Institute
The pharmaceutical multinational has chosen the Montreal Heart Institute as one of its eight world translational medicine research centres, and the only one in the world devoted to cardiometabolic disease. This innovative partnership confirms Montréal's international expertise in personalized cardiometabolic medicine and will contribute to the city's economic and social development. Read the press release (in French)
The pharmaceutical multinational has chosen the Montreal Heart Institute as one of its eight world translational medicine research centres, and the only one in the world devoted to cardiometabolic disease. This innovative partnership confirms Montréal's international expertise in personalized cardiometabolic medicine and will contribute to the city's economic and social development. Read the press release (in French)